UPDATE: Diebold Nixdorf (DBD) Tops Q2 EPS by 2c
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $68.67 +0.70%
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Income (loss) from discontinued operations: 0.01
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - July 19, 2017 6:53 AM EDT)
Diebold Nixdorf (NYSE: DBD) reported Q2 EPS of $0.08, $0.02 better than the analyst estimate of $0.06. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.1 billion.
FY EPS is seen at $0.95 to $1.15 vs consensus of $1.02 and revenue is seen at $4.70 to $4.80 billion vs $4.75 billion consensus.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Upgrades Yangzijiang Shipbuilding (YZJSGD:SP) (YSHLF) to Overweight
- UBS Downgrades Lai Yih Footwear Co Ltd (6890:TT) to Neutral
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
